PRGS · Progress Software Corporation · Stock research

even# PRGS — Progress Software Corporation

Current Thesis

The narrative leg on offer is a leveraged software roll-up being re-rated on execution: buy mature, high-renewal infrastructure software, integrate hard, compound adjusted free cash flow. Two catalysts did the work — the Q2 FY2026 beat plus FY adjusted guide raise on 2026-06-30, and the $400M Domo asset purchase announced 2026-07-22 — and the sell-side has since chased the tape rather than led it, with DA Davidson lifting its target from $45 (2026-07-23) to $55 (2026-08-12). What has changed since the last note is the extension: the last close of $43.73 (2026-08-14) sits 6.7% under a 52-week high of $46.87 after a +57.2% three-month run, with RSI(14) at 69.5 and nothing company-dated in the calendar before the Q3 FY2026 print on 2026-09-30. The narrative is maturing. The story is well known (MarkLogic 2023, ShareFile 2024, Nuclia, now Domo), it is still working — two target raises inside 20 days is fresh flow — but the incremental bid is sell-side multiple expansion on a business DA Davidson itself describes as growing ARR in the low single digits.

Bullish and bearish views on Progress Software Corporation

The model's bull view on Progress Software Corporation (PRGS), in brief: Q2 FY2026 (2026-06-30): adjusted EPS $1.62 vs $1.49 estimate; revenue $253.465M vs $242.741M estimate — a two-sided beat. The bear view: The same 2026-06-30 update cut FY2026 GAAP EPS guidance to $1.60–$1.74 from $1.71–$1.87, against a $1.75 estimate, and guided Q3 GAAP EPS to $0.35–$0.41 versus $0.43. Both cases follow in full.

Bull Case

• Q2 FY2026 (2026-06-30): adjusted EPS $1.62 vs $1.49 estimate; revenue $253.465M vs $242.741M estimate — a two-sided beat.
• FY2026 adjusted EPS guide raised to $6.09–$6.21 from $5.91–$6.03 (consensus $5.98); revenue guide raised to $990M–$1.002B (2026-06-30).
• Q3 FY2026 adjusted EPS guided $1.53–$1.59 against a $1.45 estimate (2026-06-30) — the near-term adjusted bar was set above the street.
• Shares rose 11.7% on 2026-07-01 out of a multi-quarter base; the 2026-07-22 Domo announcement stacked a second leg.
• Domo deal risk is narrower than a normal merger: it is an asset purchase, and Domo's controlling holder executed an irrevocable written consent, so there is no target shareholder vote — Domo is filing a Schedule 14C for holders of record 2026-07-22. Remaining condition is regulatory clearance, with close targeted before Progress's fiscal year end 2026-11-30.
• DA Davidson (2026-08-12, Buy, PT $55, struck at 9x its CY2026 EPS estimate) cites 85.6% gross margin, roughly 40% adjusted operating margin, and ARR growth holding in the low single digits despite AI-disruption fears.
• Progress Chef added enterprise lifecycle management and configuration for NVIDIA DGX Spark (2026-06-30); no revenue contribution has been disclosed for it.

Bear Case

• The same 2026-06-30 update cut FY2026 GAAP EPS guidance to $1.60–$1.74 from $1.71–$1.87, against a $1.75 estimate, and guided Q3 GAAP EPS to $0.35–$0.41 versus $0.43. Acquisition amortization and integration expense are the visible cost of the machine.
• Q3 revenue guidance of $244M–$250M brackets the $249.973M estimate at the top, so the revenue bar was not raised even as the adjusted EPS bar was.
• DA Davidson's $55 was set on a multiple (9x CY2026 EPS), and the reported rationale was valuation and execution rather than a change in the growth trajectory. A re-rating that comes from the multiple unwinds faster than one that comes from estimates.
• Organic growth is low single digits; acquired revenue can carry the top line while the core flattens.
• Every deal steps net debt up and the $400M Domo consideration is cash. Domo was a chronic public-market disappointer — integration, customer retention and AI-engineering attrition are live on that bet.
• Insider open-market sales printed through 2026, all under pre-arranged Rule 10b5-1 plans: Chief Legal Officer Stephanie Wang sold 5,019 shares on 2026-05-18 at weighted averages of $28.44/$29.04; Plan-driven, so weak as a directional signal, but it is supply into the move.

Setup & Price Structure

• Last close $43.73 (2026-08-14); 52-week high $46.87, leaving the tape 6.7% below its own high. RSI(14) 69.5 — at the conventional overbought boundary, not through it.
• +57.2% over three months. The 2026-07-01 session, when an insider's open-market sale executed at a weighted average $38.27, marks where the post-earnings gap zone sits; that band near $38 is the first structural shelf beneath the current tape, and there is no obvious support between here and there.
• Both live targets sit above the market: Oppenheimer maintained Outperform but lowered its target to $50 on 2026-07-01, and DA Davidson raised to $55 on 2026-08-12. Price below targets is room, not a floor.
• Crowding observables, stated plainly: two target raises from one shop within 20 days; a 6.7% drawdown from the high already in hand; RSI near 70; no earnings inside the next 30 days; no equity issuance disclosed to fund the $400M cash consideration; insider supply mechanical rather than discretionary.
• The leg continues on a reclaim and hold above $46.87. It breaks structurally on a weekly close below $38.

Catalyst Calendar (next 30 days)

• No company-dated event falls between 2026-08-16 and 2026-09-15. The window is empty; price action in it is flow and multiple, not news.
• 2026-09-30 — Q3 FY2026 earnings release and call (quarter ends 2026-08-31). The binary: whether revenue lands inside the $244M–$250M guide and whether the FY adjusted EPS range of $6.09–$6.21 survives the Domo integration accounting.
• ~2026-11-30 (est.) — targeted close of the $400M Domo asset purchase, subject to regulatory clearance; no fixed clearance date has been disclosed.

What Would Change Our Mind

Three things would break the frame. First, the structure: losing the 2026-07-01 post-earnings gap zone would erase both catalyst legs at once, and the gradeable version of that is a weekly close below $38. Second, the deal: an 8-K disclosing a second request, an antitrust block, or a termination of the Domo asset purchase before the 2026-11-30 target removes the leg added on 2026-07-22. Third, the numbers: a Q3 print on 2026-09-30 that lands revenue below the $244M guide floor, or trims the FY adjusted EPS range set at $6.09–$6.21, would show the 2026-06-30 raise was the peak of the cycle rather than the start of one. A softer but dating-able failure is price refusing to reclaim $46.87 over the coming weeks while sell-side targets keep climbing — that divergence is what would move the label from maturing to saturated.

Correlation Notes

• DOMO trades as the arbitrage proxy: it rose over 23% after hours on 2026-07-22 on the $400M agreement. Because the structure is an asset sale, the Domo shell stays listed and will rename and re-ticker after close, so DOMO's price behaviour is cash-and-shell arithmetic and reads across to PRGS only through deal-completion odds.
• The name tracks mature infrastructure-software compounders and the broad software complex more than it tracks AI capex. The 2026-06-30 NVIDIA DGX Spark integration is a product headline with no disclosed revenue attached.
• As a serial acquirer funding cash deals, it carries credit-cycle sensitivity: the cost of the roll-up rises with the cost of debt, which links it more to rate expectations than to end-market demand.
• Sector correlation is imperfect at the moment — a +57.2% three-month move sits well ahead of the low-single-digit ARR growth its own bull-case analyst describes, so a broad software de-rating would hit this harder than the fundamentals imply.